We want to hear from any user of the diabetes medication called Actos, if they have developed bladder cancer
(PRWEB) December 27, 2011
The US Drug Watchdog says, "There may be a elevated incidence of bladder cancer for users of the diabetes drug called Actos, and we want to identify every US victim, in the hopes we can get them some meaningful help. We want to identify any user of the diabetes drug called Actos, if they have developed bladder cancer, and we think we will need the help of family members, and loved ones to help get these victims identified." Actos is a member of a class of drugs known as thiazolidinediones, which have been linked to bladder cancer. Actos side effects include increased risk of congestive heart failure, and an increased risk for bladder cancer. According to the AP, "The US FDA has also issued a warning about Actos, and bladder cancer. Both Germany and France have suspended sales of Actos. The Actos suspension is effective July 11, 2011. Actos (pioglitazone), along with another diabetes drug made by Takeda Pharmaceutical, Competact, came under fire in Europe after a study revealed an increased risk for bladder cancer among diabetes patients who were taking the medication." For more information Actos users, who now have bladder cancer, or their loved ones are encouraged to call the US Drug Watchdog anytime at 866-714-6466, or contact the group via their web site at http://USDrugWatchdog.Com
The US Drug Watchdog says, "One of the biggest problems we have with respect to our drug initiative work, is the average US consumer never hears about a drug recall, or serious side effects related to a specific drug's use. If you have a friend, or loved one, who was, or is using the diabetes drug called Actos, who has developed bladder cancer, please have them call us at 866-714-6466." http://USDrugWatchdog.Com
Case number 11cv2406 BEN BGS in the Federal District Court San Diego, CA.